Saturday 02 Aug, 2025 04:21 PM
Site map | Locate Us | Login
   Tata Power Q1 PAT climbs 6% YoY to Rs 1,262 cr    G R Infra Q1 PAT surges 57% YoY to Rs 244 cr    ITC Q1 PAT rises 3% YoY to Rs 5,244 cr    Delhivery Q1 PAT climbs 68% YoY to Rs 91 cr    Oriental Rail Infra secures Rs 8.24-cr orders from Indian Railways    Honeywell Automation Q1 PAT slides 8% YoY to Rs 125 cr    NMDC iron ore production jumps 42% YoY in July 2025    RailTel Corp bags Rs 166-cr service order from BSNL    Maruti Suzuki reports 3% YoY sales growth in July 2025    Tata Motors slips as total sales slide 4% YoY in July 2025    Swiggy slides after Q1 net loss widens to Rs 1,197 cr    P&G Health spurts after PAT climbs over threefold to Rs 66 cr in Q1 FY26    SML Isuzu hits the roof after July sales climbs 19% YoY    PNB Housing Finance Ltd leads losers in 'A' group    Credo Brands Marketing Ltd leads losers in 'B' group 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Shalby gains on acquiring implant assets from Consensus Orthopedics
17-May-21   09:24 Hrs IST

The assets were acquired by Shalby Advanced Technologies Inc, a wholly owned subsidiary of Mars Medical Devices, which is a wholly owned subsidiary of Shalby. The announcement was made on Saturday, 15 May 2021.

The acquired assets are primarily comprised of inventory and plant and equipment. Product inventory includes knee systems, mobile bearing knee systems, hip systems and revision knee systems. The manufacturing plant and equipment consists of machining & finishing (60,000 components per annum), inspection (75,000-80,000 components per annum) and cleaning, packaging & sterilization (1,50,000 components per annum). The manufacturing site is USFDA certified and has ISO certification 13485:2016. In addition, an experienced team of over 40 consensus employees will be joining Shalby as part of this transaction.

Consensus Orthopedics designs and manufactures orthopedic implants and instruments with sales predominantly in North America. Key customers include hospitals, surgeons and wholesale distributors. Consensus has a long-standing track record of innovation and completed over 1,60,000 joint replacement procedures with zero recalls in the company's history, as per the press release.

Shalby engages in hip and knee replacement surgeries in India with a 15% market share in private hospitals offering joint replacement. The strategic and financial rationale for this acquisition will enable it to procure quality implants at a competitive price for its own consumption in India, build on the existing asset platform to enhance implant sales across the US and international markets and diversify its business and revenues mix. In FY2023 implant sales is expected to account for 15% of total revenues. The transaction is expected to be earnings accretive in FY2023.

The consideration for the acquired assets was $11.45 million in cash and has been funded by a combination of internal accruals and US Dollar denominated bank borrowings.

Meanwhile, after market hours on Friday, 14 May 2021, Sushobhan Dasgupta had been appointed as an additional director (non-executive) designated as vice chairman and global president of the company from Monday, 17 May 2021.

Shalby is India's leading multi-specialty hospital. It currently operates a chain of 11 multispecialty tertiary hospitals across India with an aggregate bed capacity of over 2,000 hospital beds.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 43140807
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL Securities Private Limited